Letroblock® 2,5 mg

5,34 53,40 

SKU: N/A Category:

Description

Indications

The drug is indicated for the treatment of

  • Early-stage invasive breast cancer, whose cells have hormone receptors, in postmenopausal women as adjuvant therapy.
  • Early stage invasive breast cancer in postmenopausal women after completion of standard adjuvant therapy with tamoxifen for 5 years as extended adjuvant therapy.
  • Common hormone-dependent forms of breast cancer in postmenopausal women (first-line therapy).
  • Disseminated forms of breast cancer with disease recurrence or progression in postmenopausal women (natural or induced) who have received prior anti-estrogen therapy.
  • Hormone-dependent HER-2 negative breast cancer in postmenopausal women as neoadjuvant therapy when chemotherapy is contraindicated and emergency surgery is not required.

Contraindications

  • Hypersensitivity to letrozole or any of the other components of the drug.
  • Endocrine condition specific to the reproductive period.
  • Pregnancy, lactation period.
  • Age below 18 years.

Additional information

substance active

letrozole

Amount of substance, mg

2.5

formulaire de discharge

compressed

1 compressed, mg

2.5

Plaquettes thermoformed by package, pieces

dix

manufacturer

doctor

volume de commande

1 blister of 10 compresses, 1 package (10 blisters)

Reviews

There are no reviews yet.

Be the first to review “Letroblock® 2,5 mg”

Your email address will not be published. Required fields are marked *

Select options This product has multiple variants. The options may be chosen on the product page